Hemodynamic-based Assessment and Management of Cardiogenic Shock

Abstract

Cardiogenic shock (CS) remains a deadly disease entity challenging patients, caregivers, and communities across the globe. CS can rapidly lead to the development of hypoperfusion and end-organ dysfunction, transforming a predictable hemodynamic event into a potential high-resource, intense, hemometabolic clinical catastrophe. Based on the scalable heterogeneity from a cellular level to healthcare systems in the hemodynamic-based management of patients experiencing CS, the authors present considerations towards systematic hemodynamic-based transitions in which distinct clinical entities share the common path of early identification and rapid transitions through an adaptive longitudinal situational awareness model of care that influences specific management considerations. Future studies are needed to best understand optimal management of drugs and devices along with engagement of health systems of care for patients with CS.

Keywords: Cardiogenic shock; acute decompensated heart failure; acute myocardial infarction; post-cardiotomy shock; pulmonary embolism; valvular heart disease.

Figure 1:. Clinical, Hemodynamic, and Imaging Longitudinal Profiling

Figure 2:. Hemodynamic, Device-related, and Imaging Hemodynamic Contextualization in the Weaning of Transvalvular Microaxial Flow Pumps

Figure 3:. Adoption of Real-world Data and Contemporary Classification in the Management of Heart Failure-related Cardiogenic Shock